Cover
Vol. 4 No. 1 (2026)

Published: June 1, 2026

Pages: 259-275

Review Article

Ethosomal Systems As a Novel Non-Invasive Vesicular Platform Drug Delivery

Ibtihal Abdulkadhim Dakhil 1 Mustafa M. Noori 1 Ali Khidher Abbas 1 Aqeel Abdulridha Khudhair 1
1 Department Of Pharmaceutics, College of Pharmacy, Mustansiriyah University
History
  • Received: April 2, 2026
  • Revised: May 2, 2026
  • Accepted: May 12, 2026
  • Available Online: June 1, 2026

Abstract

Objective Examine how transdermal drug delivery systems can yield advantages over conventional methods, especially in terms of maximizing efficacy while reducing toxicity and bypassing hepatic metabolism. The study also aims to review ethosomal systems as a novel nanocarrier for enhanced transdermal drug delivery. Methods A comprehensive review of transdermal drug delivery systems with an accent on ethosomes. Three types of ethosomal systems were studied based on their composition, which are transethosomes, binary ethosomes, and classical ethosomes. These methods were explored to determine how the differences in preparation techniques and formulation methods influenced system properties, including vesicle size, zeta potential, drug entrapment efficiency, skin penetration, and stability. Results Ethosomes are emerging as potent transdermal drug carriers.They can encompass drugs with a broad diversity of physicochemical properties, and due to their high ethanol levels, ethanol has been used to increase the penetration of the drug molecules by disrupting the lipid structure of the stratum corneum.(Due to the deeper skin layers,it may include the subcutaneous layer,but the target for transdermal drug delivery is that the drug is systemically absorbed before reaching this layer).  Transethosomes and binary ethosomes exhibited better flexibility and permeation than conventional ethosomes   Conclusions Ethosomal systems have better drug penetration, lower toxicity, and higher therapeutic efficacy.This makes them a promising new way to give drugs through the skin. The performance of formulation ingredients and preparation methods has a big effect on how well they work. More research and improvements to these systems could make them more useful in medicine and pharmacology.

Keywords

References

  1. Jayasawal P, Rao NGR, Jakhmola V. Microsponge as a novel drug delivery system: a review. Indo Glob J Pharm Sci. 2022;12(9):21–9. doi:10.35652/IGJPS.2022.12002.
  2. Baranauskaite J, Sefer S, Zevzikoviene A, Zevzikovas A, Ivanauskas L. Optimized enoxolone-loaded microsponges for drug delivery: a design of experiments approach. Pharmaceuticals. 2025;18(7):938. doi:10.3390/ph18070938.
  3. Singh M, Sareen R. Transdermal drug-delivery adhesion as a critical parameter. Int Res J Pharm. 2013;2(9):16–21. doi:10.7897/2230-8407.04905.
  4. Kadhum WR, Al-Zuhairy SAS, Mohamed MBM, Abdulrahman AY, Kadhim MM, Alsadoon Z, et al. A nanotechnological approach for enhancing topical drug delivery by newly developed liquid-crystal formulations. Int J Drug Deliv Technol. 2021;11(3):716–20.
  5. Patel JR. Formulation and evaluation of matrix-type transdermal patches of glibenclamide. Int J Pharm Sci Drug Res. 2015;4(Feb 2014). doi:10.25004/IJPSDR.2009.010111.
  6. Nayak D, Rathnanand M, Tippavajhala VK. Navigating skin-delivery horizon: an innovative approach in pioneering surface modification of ultradeformable vesicles. AAPS PharmSciTech. 2024;25:126. doi:10.1208/s12249-024-02825-7.
  7. Lotfollahi Z. The anatomy, physiology, and function of all skin layers and the impact of ageing on the skin. Wound Pract Res. 2024;32(1):6–10. doi:10.33235/wpr.32.1.6-10.
  8. Ahn J, Nam YS. Assessing barrier function in psoriasis and cornification models of artificial skin using non-invasive impedance spectroscopy. Adv Sci. 2024;11(34):e2400111. doi:10.1002/advs.202400111.
  9. Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug-delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758–91. doi:10.1007/s13346-021-00909-6.
  10. Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438–70. doi:10.3390/pharmaceutics7040438.
  11. Raj A, Dua K, Nair RS, Chandran CS, Alex AT. Transethosome: an ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery. Chem Phys Lipids. 2023;255:105315. doi:10.1016/j.chemphyslip.2023.105315.
  12. Ruela ALM, Perissinato AG, Lino MES, Mudrik PS, Pereira GR. Evaluation of skin absorption of drugs from topical and transdermal formulations. Braz J Pharm Sci. 2016;52(3):527–44. doi:10.1590/S1984-82502016000300018.
  13. Kim B, Cho HE, Moon SH, Ahn HJ, Bae S, Cho HD, et al. Transdermal-delivery systems in cosmetics. Biomed Dermatol. 2020;4(1):1–12. doi:10.1186/s41702-020-0058-7.
  14. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–31. doi:10.4155/tde.10.16.
  15. Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;107:447–63. doi:10.1016/j.biopha.2018.07.156.
  16. Fereig SA, El-Zaafarany GM, Arafa MG, Abdel-Mottaleb MMA. Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis. Carbohydr Polym. 2021;268:118238. doi:10.1016/j.carbpol.2021.118238.
  17. Singh S, Sharma N, Behl T, Sarkar BC, Saha HR, Garg K, et al. Promising strategies of colloidal drug-delivery-based approaches in psoriasis management. Pharmaceutics. 2021;13(11):1978. doi:10.3390/pharmaceutics13111978.
  18. Kaur IP, Kapoor P, Makhija D, Bansal M. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of voriconazole. J Drug Deliv Sci Technol. 2016;32:75–85. doi:10.1016/j.jddst.2015.11.003.
  19. Otari K, Galave V, Nadaf K, Menkudale A, Nangare P. A review: phytosomes and ethosomes as novel drug-release systems. Res Rev Drugs Drugs Dev. 2022;(May):29–47.
  20. Almuqbil RM, Aldhubiab B. Ethosome-based transdermal drug delivery: its structural components, preparation techniques, and therapeutic applications across metabolic, chronic, and oncological conditions. Pharmaceutics. 2025;17(5):583. doi:10.3390/pharmaceutics17050583.
  21. Kalra N, Choudhary S, Arora P, Arora N. Asian Journal of Pharmaceutical Research and Development. Asian J Pharm Res Dev. 2020;8(5):158–62. doi:10.22270/ajprd.v8i5.835.
  22. Zhou Y, Wei Y, Liu H, Zhang G, Wu X. Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH-gradient method. AAPS PharmSciTech. 2010;11(3):1350–8. doi:10.1208/s12249-010-9509-6.
  23. Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2012;92:299–304. doi:10.1016/j.colsurfb.2011.12.004.
  24. Rakesh R, Anoop KR. Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium. J Pharm Bioallied Sci. 2012;4(4):333–40. doi:10.4103/0975-7406.103274.
  25. Ascenso A, Raposo S, Batista C, Cardoso P, Mendes T, Praça FG, et al. Development, characterization, and skin-delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine. 2015;10:5837–51. doi:10.2147/IJN.S86186.
  26. Munde G, Satpute VM, Ghodake SR. Review on ethosomal and trans-ethosomal drug-delivery systems. Int J Pharm Sci. 2024;2(5):206–20.
  27. Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech. 2007;8(4):213–20. doi:10.1208/pt0804107.
  28. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Enhanced transdermal delivery of an antihypertensive agent via nanoethosomes: statistical optimization, characterization, and pharmacokinetic assessment. Int J Pharm. 2013;443(1–2):26–38. doi:10.1016/j.ijpharm.2013.01.011.
  29. Soba SV, Babu M, Panonnummal R. Ethosomal gel formulation of alpha-phellandrene for transdermal delivery in gout. Adv Pharm Bull. 2021;11(1):137–49. doi:10.34172/apb.2021.015.
  30. Nasr AM, Moftah F, Abourehab MAS. Design, formulation, and characterization of valsartan nanoethosomes for improving bioavailability. Pharmaceutics. 2022;14:2268. doi:10.3390/pharmaceutics14112268.
  31. Shetty BM, Miranda FC. Ethosomes: the upgraded liposomes—a review. J Adv Pharm Res. 2024;8(4):205–17.
  32. van der Koog L, Gandek TB, Nagelkerke A. Liposomes and extracellular vesicles as drug-delivery systems: a comparison of composition, pharmacokinetics, and functionalization. Adv Healthc Mater. 2022;11(5):e2100639. doi:10.1002/adhm.202100639.
  33. Abdulbaqi, I. M., Darwis, Y., Khan, N. A. K., Assi, R. A., & Khan, A. A. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. International Journal of Nanomedicine. 2016;11:2279–2304. doi:10.2147/IJN.S99035
  34. Zhang Y, Li J, Shen X, Zhang G, Yuan J. Functionalized ethosomes: recent developments, prospects, and challenges. Curr Pharm Biotechnol. 2021;22(15):1335–49. doi:10.2174/1389201022666210827113420.
  35. Natsheh H, Touitou E. Phospholipid vesicles for dermal/transdermal and nasal administration of active molecules: the effect of surfactants and alcohols on lipid-bilayer fluidity and penetration-enhancement properties. Molecules. 2020;25(13):2959. doi:10.3390/molecules25132959.
  36. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs liposomes. Biomaterials. 2000;21(18):1879–85. doi:10.1016/S0142-9612(00)00063-6.
  37. Giram J, Mahabal R, Bhosale N, Jagtap V. Review on ethosomes incorporated into gel: a novel approach for topical drug delivery. Int J Pharm Sci. 2024;2(12):462–79.
  38. Pangeni R, Singh R, Bhandari A, Parajuli P. Transethosomes: a novel strategy to enhance transdermal drug delivery. Curr Drug Deliv. 2020;17(8):635–47. doi:10.2174/1567201817666200511124854.
  39. Mohamad EA, Fahmy HM. Niosomes and liposomes as promising carriers for dermal delivery of Annona squamosa extract. Braz J Pharm Sci. 2020;56:e18096. doi:10.1590/S2175-97902019000318096.
  40. Orlu M, Cevher E, Araman A. Design and evaluation of colon-specific drug-delivery system containing flurbiprofen microsponges. Int J Pharm. 2006;318(1–2):103–17. doi:10.1016/j.ijpharm.2006.03.025.
  41. Alabada A, Mohammed M. Preparation and characterization of L-ascorbic acid ethosomal formulation for enhanced permeation. Iraqi Natl J Med. 2023;5(2):45–57.
  42. Jain N, Sharma A, Srivastava AK. Preparation and characterization of ethosomal-gel drug delivery: a comprehensive review. J Biomed Pharm Res Rev. 2024;13:79–84.
  43. Li SS, Li GF, Liu L, Jiang X, Zhang B, Liu ZG, et al. Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis. PLoS One. 2013;8(8):e79881. doi:10.1371/journal.pone.0079881.
  44. Al-Ebadi NN, Al-Lami MS. Formulation and in vitro evaluation of ethosomes using anastrozole as a model drug. Al Mustansiriyah J Pharm Sci. 2023;22(4):90–105.
  45. Sapkal B, Sapkal VB, Kanase RR, Pawar AM, Pore SP. Ethosomes: a review. Int J Creat Res Thoughts. 2023;11(6):68–76.
  46. Pandey K, Nimisha. An overview on promising nanotechnological approaches for the treatment of psoriasis. Recent Pat Nanotechnol. 2020; 14(2): 102-118. doi:10.2174/1872210514666200204124130
  47. Abubakr AH, Ibrahem AE, Salah M. Ethosomes: a potential nanocarrier for transdermal drug delivery. ERU Research Journal. 2023; 2: 161-176. doi:10.21608/ERURJ.2023.190245.1010
  48. Roge AB, Firke SN, Gunjkar VN, Ghiware NB. Study about Ethosomes: a novel approach in transdermal drug delivery system. Curr Overv Pharma Sci. 2023; 2: 106-115. doi:10.9734/bpi/cops/v2/17078D
  49. Nainwal N, Jawla S, Singh R, Saharan VA. Transdermal applications of ethosomes—a detailed review. J Liposome Res. 2019; 29(2): 103-113. doi:10.1080/08982104.2018.1517160
  50. Niu J, Yuan M, Li H, et al. Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin. Drug Deliv. 2022; 29(1): 1800-1810. doi:10.1080/10717544.2022.2081739
  51. Pilch E, Musiał W. Liposomes with an ethanol fraction as an application for drug delivery. Int J Mol Sci. 2018; 19(12): 3806. doi:10.3390/ijms19123806
  52. Zhao J-H, Ji L, Wang H, et al. Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo. Int J Nanomedicine. 2011; 6: 1611-1619. doi:10.2147/IJN.S23597
  53. Ansari SA, Qadir A, Warsi MH, et al. Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: in vitro investigations and preclinical assessment. 3 Biotech. 2021; 11(11): 456. doi:10.1007/s13205-021-02978-3
  54. Dhara A, Majumder S, Pahari S, Kar D. Improved targeting of therapeutics by nanocarrier-based delivery in cancer immunotherapy and their future perspectives. BioNanoScience. 2023; 1-22: 278-299. doi:10.1007/s12668-023-01065-6
  55. Cândido TM, De Oliveira CA, Ariede MB, Velasco MVR, Rosado C, Baby AR. Safety and antioxidant efficacy profiles of Rutin-loaded Ethosomes for topical application. AAPS PharmSciTech. 2018; 19(4): 1773-1780. doi:10.1208/s12249-018-0994-3
  56. Esposito E, Calderan L, Galvan A, et al. Ex vivo evaluation of Ethosomes and Transethosomes applied on human skin: a comparative study. Int J Mol Sci. 2022; 23(23):15112. doi:10.3390/ijms232315112
  57. Akhtar N, Akhtar N, Menaa F, et al. Fabrication of ethosomes containing tocopherol acetate to enhance transdermal permeation: In vitro and ex vivo characterizations. Gels. 2022; 8(6): 335. doi:10.3390/gels8060335
  58. Kumar B, Sahoo PK. Potential of ethosomes for enhanced transdermal drug delivery in skin diseases. Nanomedicine J. 2022; 9(4): 273-280. doi:10.22038/NMJ.2022.66753.1703
  59. Avasarala H, Dinakaran S, Boddeda B, Dasari SP, Jayanthi VR, Swaroopa P. Ethosomal gel: a novel choice for topical delivery of the antipsychotic drug ziprasidone hydrochloride. Braz J Pharm Sci. 2022; 58:e19317. doi:10.1590/s2175-97902022e19317
  60. Kumar S, Kumar A, Kumar N, et al. In vivo therapeutic efficacy of Curcuma longa extract loaded ethosomes on wound healing. Vet Res Commun. 2022; 46(4): 1033-1049. doi:10.1007/s11259-022-09952-1
  61. Ajikumar A, Dharan SS, Chandra SM, Soman M, Mathew LT. Formulation and evaluation of Ethosomal gel containing clarithromycin for the treatment of acne vulgaris. J Pharm Sci Res. 2022; 14(7): 825-833.
  62. Kadhim ZM, Saeed AM, Sabry HS, Hammoodi ID. Ethosomes as pharmaceutical novel drug delivery technique. Science. 2022; 25: 3.
  63. Sguizzato M, Mariani P, Spinozzi F, et al. Ethosomes for coenzyme Q10 cutaneous administration: from design to 3D skin tissue evaluation. Antioxidants (Basel, Switzerland). 2020; 9(6): 485. doi:10.3390/antiox9060485
  64. Jain S, Jain P, Umamaheshwari RB, Jain NK. Ethosomes: a novel delivery system for enhanced transdermal delivery of 5-fluorouracil. Trop J Pharm Res. 2008; 7(3): 1055-1066.
  65. Tiwari, A., Tiwari, V., Palaria, B., & Kaushik, D. Microsponges: a breakthrough tool in pharmaceutical research. Future Journal of Pharmaceutical Sciences. 2022;8:31. doi:10.1186/s43094-022-00421-9
  66. Lamsal R, Geethalakshmi A, Gubbala S. Formulation and evaluation of gliclazide ethosomes as a novel drug carrier. International journal of pharmaceutical sciences and research. 2015 May 1;6(5):2072.
  67. Darekar, A., Pawar, P., & Saudagar, R. B. A Review on Microsponge as Emerging Drug Delivery System. Journal of Drug Delivery & Therapeutics. 2019;9(3-s):793–801. doi:10.22270/jddt.v9i3-s.2828
  68. Kapoor, D., Patel, M., Vyas, R. B., Lad, C., & Tyagi, B. L. A Review on Microsponge Drug Delivery System. Journal of Drug Delivery & Therapeutics. 2014;4(5):29–35. doi:10.22270/jddt.v4i5.978
  69. Monika, Dua, J. S., Prasad, D. N., Hans, M., & Sharma, R. Novel Strategy: Microsponges for Topical Drug Delivery. Journal of Drug Delivery & Therapeutics. 2019;9(3-s):1024–31. doi:10.22270/jddt.v9i3-s.2935
  70. Liu, Q., Hong, J., Chen, H., & Xiang, S. Toward application of microsponges in transdermal drug delivery system. MOJ . 2015;1(1):7–12. doi:10.15406/mojbb.2015.01.00003
  71. Vinay, H. S., Krishna, K. R., Parthiban, S., & Anupama, H. B. Microsponge gel in transdermal delivery: a comprehensive review of its role, benefits, enhanced skin penetration and efficacy. World Journal of Pharmaceutical Research. 2025;14(7):599–613. doi:10.20959/wjpr20257-36093
  72. Lendave, A. S. Microsponge Technology for Innovative Drug Delivery System. IJSRST. DOI:10.32628/IJSRST207521
  73. Hans, M., Dua, J. S., Prasad, D. N., Sharma, D., & Monika. A Review on Microsponge Delivery System. Journal of Drug Delivery & Therapeutics. 2019;9(3-s):1032–40. doi:10.22270/jddt.v9i3-s.2938
  74. World Journal of Advanced Research and Reviews. Microsponge: An adaptable topical drug delivery system. 2022;15(1):396–411.
  75. Tiwari, A., Tiwari, V., Palaria, B., Kaushik, D., & others. Microsponges: A breakthrough tool in pharmaceutical research. Future Journal of Pharmaceutical Sciences. 2022;8:31.
  76. Arunakumari, D. R., Srivalli, K., & Babu, M. N. Ethosomes: A Comprehensive Review of Their Role in Enhanced Transdermal Drug Delivery. Pharmaceutical Research: Recent Advances and Trends. 2024;8:143–154. doi:10.9734/bpi/prrat/v8/2921
  77. Pakhale, N. V., Gondkar, S. B., & Saudagar, R. B. Ethosomes: Transdermal Drug Delivery System. Journal of Drug Delivery & Therapeutics. 2019;9(3):2692. doi:10.22270/jddt.v9i3.2692
  78. Abubakr, A.-H., Othman, A. I., & Salah, M. Ethosomes: a potential nanocarrier for transdermal drug delivery. ERU Research Journal. 2023;2(1):161–176. doi:10.21608/erurj.2023.190245.1010
  79. Waqar, M. A., Zaman, M., Hameed, H., & Munir, M. Ethosomes: A Novel Approach for the Delivery of Drug. International Journal of Pharmacy & Integrated Health Sciences. 2023;4(2):31–46. doi:10.56536/ijpihs.v4i2.93
  80. Devaki, J., Pavuluri, S., & Suma, N. Ethosomes: A Vesicular Carrier as a Novel Tool for Transdermal Drug Delivery System. Journal of Drug Delivery & Therapeutics. 2023;13(4):159–164. doi:10.22270/jddt.v13i4.5796
  81. Shetty, B. M., & Miranda, F. C. Ethosomes: The Upgraded Liposomes – A Review. Journal of Advanced Pharmacy Research. 2024;8(4):205–217. doi:10.21608/aprh.2024.295469.1274
  82. Azzahra, L., Mita, S. R., & Sriwidodo, S. Formulation, Characterization, and Herbal Drug Delivery Applications of Ethosome, Transfersome, and Transethosome. Indonesian Journal of Pharmaceutics. 2020;2(3).
  83. Zafer, I. M., & El-Din, M. A. Binary ethosomes: preparation, characterization and in vitro skin permeation of eletriptan hydrobromide. Journal of Liposome Research. 2018;28(2):129–142. doi:10.1080/08982104.2017.1402089
  84. Verma, P., Pathak, K. Therapeutic and cosmeceutical potential of ethosomes: An overview. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(3):97–103. doi:10.4103/2231-4040.73404
  85. Kanazawa, T., & Ozeki, T. Effects of ethanol and oleic acid on the transdermal delivery of propranolol from ethosomes. International Journal of Pharmaceutics. 2016;515(1–2):470–478. doi:10.1016/j.ijpharm.2016.10.013
  86. Moolakkadath, T., Aqil, M., Ahad, A., Imam, S. S., Praveen, A., Sultana, Y., et al. Fisetin loaded binary ethosomes for management of skin cancer by dermal application. International Journal of Pharmaceutics. 2019;560:78–91. doi:10.1016/j.ijpharm.2019.01.009
  87. Pandey, V., Golhani, D., & Shukla, R. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Delivery. 2015;22(8):988–1002. doi:10.3109/10717544.2014.945483
  88. Németh Z, Csóka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality-by-design-driven zeta-potential optimisation study of liposomes with charge-imparting membrane additives. Pharmaceutics. 2022;14(9):1798. doi:10.3390/pharmaceutics14091798.
  89. Jafari, A., Daneshamouz, S., Ghasemiyeh, P., & Mohammadi-Samani, S. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization. Journal of Liposome Research. 2023;33(1):34–52. doi:10.1080/08982104.2022.2150660
  90. Hesham, H., Al-Sawahli, M., & Mokhtar, R. Tofacitinib citrate-loaded transethosomes for topical delivery: formulation, characterization, and ex vivo skin permeation. AAPS PharmSciTech. 2024;25:41.
  91. Arora, K., Kaur, A., Kumar, S., & Jagwani, S. Ultra-deformable vesicles: transethosomes for enhanced skin delivery of thymoquinone. AAPS PharmSciTech. 2025.
  92. Madan, J., & Khuller, G. K. Liposome mediated DNA vaccination induces CD4 + and CD8 + T-cell immunity and protects against experimental tuberculosis. Infection and Immunity. 2004;72(1):46–56. doi:10.1128/IAI.72.1.46-56.2004
  93. Attari, F., Sankala, H., & Kalepu, S. Transfersomes: a review of the present status and future potential. International Journal of Research in Pharmacy and Biosciences. 2015;2(4):1–9.
  94. Cevc, G., & Blume, G. Lipid vesicles penetrated by surface-active agents: transdermal drug carriers with improved efficiency. Biochimica et Biophysica Acta (BBA) – Biomembranes. 1992;1104(1):226–232. doi:10.1016/0005-2736(92)90125-4
  95. Elsayed, M. M. A., Abdallah, O. Y., & Naggar, V. F. Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. International Journal of Pharmaceutics. 2006;322(1–2):60–69. doi:10.1016/j.ijpharm.2006.06.025
  96. Jain, A., Jain, S., Umamaheshwari, R. B., & Jain, N. K. Ethosomes: a novel delivery system for enhanced transdermal delivery of 5-fluorouracil. Tropical Journal of Pharmaceutical Research. 2008;7(3):1055–1066. doi:10.4314/tjpr.v7i3.14662
  97. Mozafari, M. R., Flanagan, J., Matia-Merino, L., Awati, A., Suntres, Z., & Pardoe, H. Skin delivery of drugs using liposomes and ethosomes. In: Cunta, F., Journal of Liposome Research. 2008;18(2):73–78. doi:10.1080/08982100701864795
  98. Al-Sou’od, K. M., Syed, S., & Khan, M. A. Optimisation of ethosomal gel to improve the transdermal delivery of captopril. Journal of Liposome Research. 2020;30(1):89–102. doi:10.1080/08982104.2019.1698428
  99. Patel, H. D., & Anand, P. Cubosomes and ethosomes: A comparative study for transdermal delivery of an anti-inflammatory drug. Journal of Drug Delivery Science and Technology. 2021;62:102317. doi:10.1016/j.jddst.2020.102317
  100. El-Zaafarany, G. M., & Nahas, A. M. Ethosome-based transdermal delivery of simvastatin: optimization, characterization, and in vivo evaluation. International Journal of Pharmaceutics. 2010;386(1–2):232–241. doi:10.1016/j.ijpharm.2009.11.019
  101. Ahmed, A., & Chakraborty, S. Nanoethosomes for enhanced dermal delivery of acyclovir: in vitro and in vivo evaluation. Journal of Pharmaceutical Sciences. 2019;108(3):1175–1183. doi:10.1016/j.xphs.2018.10.013 102- Chauhan N, Vasava P, Khan SL, Siddiqui FA, Islam F, Chopra H, Emran TB. Ethosomes: A v novel drug carrier. Annals of Medicine and Surgery. 2022 Oct 1;82.